Ask Question
Sign Guest book

 
About Lymphoma
| Advocacy & Art | CAM & Life Style | Clinical trials | Doctors & Centers  | Guidelines  at  Diagnosis | How  to   Help  | Research | Side Effects  | Support | Symptoms  | Tests | Treatments


WebCasts

Treatment Overview

  

Lymphomation.org > Treatments

Last update: 02/26/2008

Help Us Help Others

Also see:  Categorized Resources | WebCasts | Experts on Treatment of Lymphomas

Antibodies (monoclonal) such as Rituxan

Biologics  such as Interferon, Neupogen, Leukine ...

Bone marrow (stem cell) transplants  

AllogeneicMini / Autologous 
Comparing Auto and Allo SCT
Cord blood
type 
HLA-typing | Background
Harvesting / Mobilizing stem cells 
Graft vs Host Disease | Patient stories  Resources 
  

Chemotherapy

Alphabetical index of individual agents
Agents (individual) grouped by mechanism  
CHOP chemotherapy  
Common chemo protocols (APO...VBM)  
Liposomal (encapsulated) types 
Low dose (metronomic) chemotherapy PEP-C Outcome abstracts - Frontline Treatment support for chemotherapy

Clinical Trials

Lymphoma subtype 
T
reatment type  

State or Country
 
Other  - age ... stage, phase, refractory  
Clinical Trials of Interest for Lymphoma

Complementary and Alternative Medicine

Elderly patients - treatment protocols and resources

Emerging Therapies and Targets index of investigative therapies &  treatment targets, containing brief explanations.
 
     Also see
Pipeline with links to clinical trials

Evaluating medical claims recognizing bias; limits of abstracts, what makes information credible.

Immune-based therapies

Lower toxic treatments  

MDS (Myelodysplastic Syndrome)

Nanotechnology

Photopheresis 

Pipeline new agents with links to clinical trials

Pregnancy During Lymphoma Treatment

Progress Review Group  (PRG) research objectives

Quality of life

Radio-immunotherapy

Bexxar  ... centers
Zevalin
  ... centers 
Comparing Bexxar/Zevalin 
RIT for bulky disease?

Radiofrequency Ablation (RFA)?

Radiotherapy

Side effects | Treatment support for  

Refractory lymphomas  
abstracts on protocols for 
treating lymphomas resistant to standard therapies

Protocols | Clinical Trials

Remissions & Response background & terms

Also Spontaneous regressions

Rituxan - Basics ... Side effects ...
 
               Check list what to expect, bring, do

     Abstracts on outcomes

Side effects common to treatments

Splenectomy

Stem cell Transplant

Surgery for Lymphoma? (a common question)

Therapy-related risks balancing risks and benefits

Treatment Decisions - Factors that Influence

Goals | Types | Outcomes | Interventions  

Considerations at relapse

Factors that determine treatment and timing

Outcome abstracts

Strategy for treating indolent lymphomas - 
FDA Flow chart
 

NCCN Clinical Practice Guidelines in Oncology™ NHL, 2008 nccn.org  PDF 

Treatment Timing?

Treatment goals, types, outcomes and interventions - overview from patients

Time to Progression comparing protocols for first line treatment of indolent NHL | Frontline

Treatment settings - frontline, relapse, survival

Watchful Waiting

Transformation background and treatment

Vaccines - investigational patient-specific therapeutic vaccines

Categorized abstracts | Outcome Data

 
Disclaimer:  The information presented on Lymphomation.org is not intended to be a substitute for 
professional medical advice or to replace your relationship with a physician.
For all medical concerns,  you should always consult your doctor. 
Patients Against Lymphoma, Copyright © 2004,  All Rights Reserved.